Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Audag Nicolas (Brussels, Belgium), Audag Nicolas, Liistro Giuseppe, Leal Teresinha, Reychler Gregory. Compared efficacies of lung delivery using two nebulizers in the prophylaxis against pneumocystis carinii pneumonia. Eur Respir J 2016; 48: Suppl. 60, 2649

Member's Comments

No comment yet.

Related content which might interest you: Prognosis of pneumocystis jirovecii pneumonia in non-HIV patients Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Pneumocystis pneumonia in the non-HIV population Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Outbreak of pneumocystis jiroveci pneumonia among renal transplant patients Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Pneumocystis jirovecii pneumonia prophylaxis in non-HIV infected patients on immunosuppression; a regional cross-sectional study Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Efficacy of corticosteroids in hospital treated community-acquired pneumonia Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Are corticosteroids useful in community-acquired pneumonia? Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006 Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis? Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients Source: Eur Respir J 2003; 22: 77S-83S Year: 2003 Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Pulmonary embolism or Pneumocystis jiroveci pneumonia? Source: ISSN=ISSN 1810-6838, ISBN=, page=83 Year: 2006 Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010 Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia Source: Eur Respir Rev 2007; 16: 45-49 Year: 2007 Assessement of pulmonary TB in association with pneumocystis jiroveci Source: Annual Congress 2008 - Difficult tuberculosis cases Year: 2008 Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia Source: ERS Course 2018 - Respiratory Infections Year: 2018 Pneumocystis jiroveci Pneumonia prophylaxis in patients treated with mycophenolate mofetil for interstitial lung disease Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 Nebulised colistin for ventilator-associated pneumonia prevention Source: Eur Respir J 2015; 46: 1732-1739 Year: 2015 Pneumocystis carinii pneumonia in an otherwise healthy patient Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP) Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013